MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-12-2025
Sintx Technologies General and Administrative Expenses 2011-2026 | SINT
General and Administrative Expenses — these are a part of a company's operating expenses that are not directly related to the production of goods or the provision of services but are necessary for the overall functioning of the business.What these expenses include
- Salaries of administrative staff (executives, HR, accountants, legal personnel)
- Office rent and utilities
- Office equipment and IT infrastructure
- Professional services (auditors, lawyers, consultants)
- Insurance
- General administrative travel and representation expenses
- Cost control
A high level of such expenses may indicate inefficient management or an overly complex structure - Profitability
Reducing administrative expenses while maintaining stable revenue increases operating profit - Comparative analysis
Investors can compare this metric as a percentage of revenue among companies in the same industry - Business flexibility
Companies with a flexible and controlled expense structure are more resilient to revenue declines
Annual General and Administrative Expenses Sintx Technologies
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4.22 M | 3.99 M | 3.6 M | 4.38 M | 2.91 M | 4.55 M | 4.38 M | 6.29 M | 6.44 M | 13.6 M | 5.76 M | 7.31 M | 7.26 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 13.6 M | 2.91 M | 5.74 M |
Quarterly General and Administrative Expenses Sintx Technologies
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.1 M | 1.31 M | 1.16 M | - | 802 K | 1.07 M | 1.12 M | - | 990 K | 1.17 M | 1.17 M | - | 1.07 M | 993 K | 856 K | - | 933 K | 858 K | 1 M | - | 827 K | 826 K | 764 K | - | 714 K | 615 K | 971 K | - | 654 K | 935 K | 1.31 M | - | 901 K | 1.08 M | 1.11 M | - | 1.91 M | 1.36 M | 1.56 M | - | 1.43 M | 1.33 M | 2.03 M | - | 2.94 M | 6.28 M | 3.08 M | - | 1.19 M | 1.49 M | 1.38 M | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 6.28 M | 615 K | 1.37 M |
General and Administrative Expenses of other stocks in the Medical devices industry
| Issuer | General and Administrative Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Acutus Medical
AFIB
|
14.1 M | - | -26.83 % | $ 2.62 M |  USA |
 |
Allied Healthcare Products
AHPI
|
7.11 M | - | 3.58 % | $ 2.21 M | USA |
 |
Alphatec Holdings
ATEC
|
499 M | $ 12.37 | -4.85 % | $ 1.86 B | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
25.6 M | - | - | $ 1.77 B | USA |
 |
Aziyo Biologics
AZYO
|
14.1 M | - | 1.37 % | $ 20.5 M | USA |
 |
Electromed
ELMD
|
39.3 M | $ 24.26 | -0.12 % | $ 205 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
8.78 M | - | -5.86 % | $ 30.6 M | USA |
 |
Bruker Corporation
BRKR
|
894 M | $ 38.61 | 0.29 % | $ 5.75 K | USA |
 |
FONAR Corporation
FONR
|
23.5 M | $ 18.59 | 0.32 % | $ 122 M | USA |
 |
Cognyte Software Ltd.
CGNT
|
163 M | $ 8.29 | 1.22 % | $ 595 M |  Israel |
 |
Conformis
CFMS
|
28.8 M | - | - | $ 16.4 M | USA |
 |
AdaptHealth Corp.
AHCO
|
382 M | $ 9.7 | 0.31 % | $ 1.31 B | USA |
 |
Apollo Endosurgery
APEN
|
20.6 M | - | - | $ 475 M | USA |
 |
Cardiovascular Systems
CSII
|
171 M | - | 0.15 % | $ 844 M | USA |
 |
CONMED Corporation
CNMD
|
132 M | $ 41.54 | -3.37 % | $ 1.29 B | USA |
 |
EDAP TMS S.A.
EDAP
|
5.9 M | $ 4.19 | -1.41 % | $ 156 M |  France |
 |
Cutera
CUTR
|
63.3 M | - | -10.19 % | $ 1.99 M | USA |
 |
CryoLife, Inc.
CRY
|
141 M | - | -4.14 % | $ 702 M | USA |
 |
Avinger
AVGR
|
14.1 M | - | -20.74 % | $ 369 K | USA |
 |
AxoGen
AXGN
|
44.6 M | $ 29.14 | -0.27 % | $ 1.34 B | USA |
 |
Apyx Medical Corporation
APYX
|
22.2 M | $ 3.26 | -1.21 % | $ 113 M | USA |
 |
Axonics Modulation Technologies
AXNX
|
40.2 M | - | - | $ 3.31 B | USA |
 |
Dynatronics Corporation
DYNT
|
8.46 M | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
54.3 M | - | - | $ 10.2 M | USA |
 |
Soliton, Inc.
SOLY
|
8.46 M | - | -1.42 % | $ 435 M | USA |
 |
Pulmonx Corporation
LUNG
|
102 M | $ 1.59 | 10.07 % | $ 62.2 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
4.88 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
8.5 M | - | 0.03 % | $ 1.58 B | Israel |
 |
Second Sight Medical Products
EYES
|
806 K | - | -0.97 % | $ 54.4 M | USA |
 |
Accuray Incorporated
ARAY
|
47.9 M | $ 0.51 | -2.68 % | $ 52.4 M | USA |
 |
Misonix, Inc.
MSON
|
18 M | - | - | $ 462 M | USA |
 |
Medtronic PLC
MDT
|
10.8 B | $ 92.77 | -2.97 % | $ 119 B | USA |
 |
Neovasc
NVCN
|
14.7 M | - | - | $ 111 M |  Canada |
 |
Cytosorbents Corporation
CTSO
|
35 M | $ 0.81 | 1.92 % | $ 44.1 M | USA |
 |
Align Technology
ALGN
|
1.76 B | $ 174.88 | -4.0 % | $ 13.1 B | USA |
 |
Intersect ENT, Inc.
XENT
|
98.6 M | - | - | $ 955 M | USA |
 |
Butterfly Network
BFLY
|
39.8 M | $ 3.69 | -8.56 % | $ 781 M | USA |
 |
BIOLASE
BIOL
|
10.2 M | - | -13.19 % | $ 166 K | USA |
 |
Abbott Laboratories
ABT
|
12.3 B | $ 110.83 | -2.01 % | $ 193 B | USA |
 |
InMode Ltd.
INMD
|
8.41 M | $ 13.48 | -0.57 % | $ 871 M | Israel |
 |
Orthofix Medical
OFIX
|
554 M | $ 12.56 | -2.41 % | $ 497 M |  Curacao |
 |
BioSig Technologies
BSGM
|
11.6 M | - | 37.08 % | $ 85.7 M | USA |
 |
Boston Scientific Corporation
BSX
|
6.89 B | $ 72.16 | -0.07 % | $ 107 B | USA |
 |
IRadimed Corporation
IRMD
|
15.9 M | $ 99.47 | -5.37 % | $ 1.26 B | USA |
 |
Insulet Corporation
PODD
|
1.16 B | $ 239.77 | -1.29 % | $ 16.9 B | USA |
 |
Profound Medical Corp.
PROF
|
10.3 M | - | - | $ 180 M | Canada |
 |
IRIDEX Corporation
IRIX
|
8.75 M | $ 1.4 | -0.71 % | $ 22.6 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
120 M | $ 17.63 | -4.6 % | $ 414 M | USA |